Trastuzumab-DM1: Building a Chemotherapy-Free Road in the Treatment of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

被引：38
|
作者：
Isakoff, Steven J. [1 ]
Baselga, Jose [1 ]
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
MONOCLONAL-ANTIBODY; ADJUVANT CHEMOTHERAPY; INHIBITOR; PLUS; COMBINATION; PERTUZUMAB; LAPATINIB; EFFICACY; THERAPY; COMPLEX;
D O I：
10.1200/JCO.2010.31.6679
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：351 / 354
页数：4
相关论文
共 50 条
  • [1] Trastuzumab: A Milestone in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Dhanushkodi, Manikandan
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (01) : 54 - 56
  • [2] Lapatinib plus trastuzumab in pretreated human epidermal growth factor receptor 2-positive metastatic breast cancer
    Sotelo, Miguel J.
    Angel Garcia-Saenz, Jose
    Manso, Luis
    Moreno, Fernando
    Ciruelos, Eva
    Callata, Hector R.
    Mendiola, Cesar
    Cabezas, Santiago
    Ghanem, Ismael
    Diaz-Rubio, Eduardo
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (04) : 967 - 972
  • [3] Trastuzumab emtansine in advanced human epidermal growth factor receptor 2-positive breast cancer
    Van den Mooter, Tom
    Teuwen, Laure-Anne
    Rutten, Annemie
    Dirix, Luc
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (05) : 749 - 760
  • [4] Trastuzumab emtansine in human epidermal growth factor receptor 2-positive breast cancer: a review
    Mathew, Jacob
    Perez, Edith A.
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (06) : 594 - 600
  • [5] Efficacy and tolerability of trastuzumab emtansine in advanced human epidermal growth factor receptor 2-positive breast cancer
    Yeo, Winnie
    Luk, M. Y.
    Soong, Inda S.
    Yuen, Tony Y. S.
    Ng, T. Y.
    Mo, Frankie K. F.
    Chan, K.
    Wong, S. Y.
    Tsang, Janice
    Leung, Carmen
    Suen, Joyce J. S.
    Ngan, Roger K. C.
    HONG KONG MEDICAL JOURNAL, 2018, 24 (01) : 56 - 62
  • [6] Adjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Detour on the Road to a Cure
    Sledge, George W., Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (10) : 1021 - +
  • [7] A shift in the treatment of hormone receptor and human epidermal growth factor receptor 2-positive metastatic breast cancer
    Kemp, Zoe
    Jones, Alison
    ADVANCES IN THERAPY, 2011, 28 (08) : 603 - 614
  • [8] Understanding the Mechanisms Behind Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Spector, Neil L.
    Blackwell, Kimberly L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (34) : 5838 - 5847
  • [9] Updates on the treatment of human epidermal growth factor receptor type 2-positive breast cancer
    Kim, Miriam
    Agarwal, Surbhi
    Tripathy, Debu
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2014, 26 (01) : 27 - 33
  • [10] Management of Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Pernas, Sonia
    Tolaney, Sara M.
    JCO ONCOLOGY PRACTICE, 2021, 17 (06) : 320 - +
12345